• $51,172.00
    Market Cap
  • -99.31%
    1-Year Change
  • Pharmaceutical Retailers
    Industry
Annual
Quarterly
12/31/2022
12/31/2021
12/31/2020
Income Statement
Total Operating Revenue
489,145
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
756
-42.94%
1,325
-48.34%
2,565
N/A
Gross Profit
488,389
+235.12%
145,734
-76.41%
617,772
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
0
N/A
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
6,165
-3.57%
6,393
-6.82%
6,861
N/A
Total Operating Expenses
473,414
-51.51%
976,386
+46.07%
668,418
N/A
Operating Profit
-473,414
-51.51%
-976,386
+46.07%
-668,418
N/A
Interest Income
N/A
N/A
-200,318
-151.62%
388,099
N/A
Interest Expense
N/A
N/A
0
+100.00%
-53,821
N/A
Interest Income and Expense and Net
0
+100.00%
-200,318
-472.19%
53,821
N/A
Total Nonoperating Income and Expense
-7.4M
N/A
N/A
N/A
480,410
N/A
Income before Taxes
-7.9M
+611.10%
-1.1M
-3.83%
-1.1M
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-7.9M
+611.10%
-1.1M
-3.83%
-1.1M
N/A
Net Income from Continuing Operations Applicable to Common
-7.9M
+611.10%
-1.1M
-3.83%
-1.1M
N/A
Basic EPS and Net Income
-0.09
+800.00%
-0.01
-50.00%
-0.02
N/A
Diluted EPS and Net Income
-0.09
+800.00%
-0.01
-50.00%
-0.02
N/A
Basic Weighted Average Shares
91.1M
+2.21%
89.1M
+37.70%
64.7M
N/A
Diluted Weighted Average Shares
91.1M
+2.21%
89.1M
+37.70%
64.7M
N/A
Balance Sheet
Cash and Cash Equivalents
0
N/A
N/A
N/A
N/A
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
0
N/A
0
N/A
0
N/A
Total Current Assets
1.4M
-84.69%
9.4M
-1.06%
9.5M
N/A
Accumulated Depreciation
53,115
+13.13%
46,949
+15.76%
40,556
N/A
Property and Plant and Equipment and Net
2,358
-72.34%
8,524
-42.86%
14,917
N/A
Total Long-Term Assets
2,358
-99.97%
9.4M
-1.06%
9.5M
N/A
Total Assets
2,358
-99.97%
9.4M
-1.12%
9.5M
N/A
Income Taxes Payable
N/A
N/A
529,948
+485.22%
90,556
N/A
Total Short-Term Debt
50,689
-94.41%
906,756
+3.39%
877,013
N/A
Total Current Liabilities
1.4M
-55.07%
3.1M
+10.49%
2.8M
N/A
Total Long-Term Debt
125,000
0.00%
125,000
0.00%
125,000
N/A
Total Long-Term Liabilities
754,440
-55.38%
1.7M
+1,274.79%
122,985
N/A
Total Liabilities
1.4M
-55.07%
3.1M
+10.49%
2.8M
N/A
Retained Earnings
-23.5M
+50.13%
-15.7M
+7.58%
-14.6M
N/A
Total Stockholders Equity
-1.4M
-121.71%
6.3M
-5.91%
6.7M
N/A
Total Shares Outstanding
71.2M
-21.94%
91.2M
+3.05%
88.5M
N/A
Cash Flow
Cash from Operating Activities
-207,265
+290.15%
-53,125
-90.23%
-543,624
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
207,265
+290.15%
53,125
-90.23%
543,624
N/A
Financials Ratio
Gross Margin
99.85%
N/A
N/A
N/A
N/A
N/A
Operating Margin
-96.78%
N/A
N/A
N/A
N/A
N/A
Return on Assets
-167.17%
N/A
N/A
N/A
N/A
N/A
Return on Equity
-316.97%
N/A
N/A
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.04
N/A
N/A
N/A
N/A
N/A
Cash Ratio
0.00
N/A
N/A
N/A
N/A
N/A
Debt-to-Equity Ratio
-0.13
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
74.51
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow